Chemomab Therapeutics Ltd (CMMB)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -6.25M | -8.32M | -8.64M | -9.05M | -8.2M | -4.37M | -3.85M | -4.05M |
| Pre Tax Income | -6.73M | -8.08M | -8.26M | -8.73M | -7.94M | -4.14M | -3.42M | -3.87M |
| Net Income | -6.19M | -8.08M | -8.27M | -8.75M | -7.97M | -4.08M | -3.42M | -3.87M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -6.25M | -8.32M | -8.64M | -9.05M | -8.2M | -4.37M | -3.85M | -4.05M |
| EBITDA | -6.24M | -8.3M | -8.63M | -9.03M | -8.18M | -4.35M | -3.9M | -4.05M |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| ILS (ILS) | ILS (ILS) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -17.78M | -33.71M | -13.04M | -22.9M | -11.71M | -12.37M | -28.53M | -25.46M |
| Pre Tax Income | -17.65M | -34.07M | -12.66M | -27.12M | -11.61M | -12.48M | -28.18M | -24.22M |
| Net Income | -18.17M | -35.23M | -13.28M | -27.12M | -11.61M | -12.48M | -27.65M | -24.22M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.372 | -0.366 | -0.853 | -0.731 | -0.313 | -0.055 | -0.125 | -0.085 |
| EBIT | -17.78M | -33.71M | -13.59M | -22.9M | -11.71M | -12.37M | -28.53M | -25.46M |
| EBITDA | -17.63M | -33.54M | -12.98M | -22.62M | -11.63M | -12.33M | -28.48M | -25.39M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
